Find your next M&A target

Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.

Search Seller Projects – ,

Page of 19
Asia: South Korea

Korean medical equipment company seeks USD 100 million equity financing or JV partners

The Korean medical equipment company mainly focuses on researching and manufacturing anti-fall wheelchairs, which can prevent wheelchair fall accidents. Meanwhile, the company has also launched information and communications technology products, wheelchair safety accessories and products suitable for new materials. Its wheelchair braking system has been recognized by Korea Invention Promotion Association and selected as a priority purchase item for excellent inventions. The company has won many awards including the Seoul International Invention Fair Grand Prize Award. As of 2020, more than 60 patents of the company have already been applied or are under application stage. In 2020, the company passed the Food and Drug Administration certification and has cooperated with companies such as Rehasense and Vermeiren International. Now the company seeks USD 100 million equity financing or to set up a joint venture.
Asia: South Korea

Korean cancer treatment company seeks investment

The Korean cancer treatment company has a bioelectronic nose sensor which can detect cancer earlier than other sensors or instruments on the market. The examinee only needs to exhale on the inspection machine for about 1 minute to complete the inspection, and there is no discomfort during the inspection process. At present, the company has cooperated with Seoul National University Cancer Hospital, Renji Hospital, Korea Institute of Science and Technology (KIST), etc. The company seeks investment now.
Asia: South Korea

Korean new hygroscopic polymers company seeks USD 1.68 million equity financing

The Korean new hygroscopic polymers company produces humidity controllers and dehumidifier papers. Its humidity controllers are designed through self-developed "Green & Healthy" patented technology. Its dehumidifier papers can be used for equipments and materials with special purposes, but also normal daily dehumidification needs. The company is one of the entrepreneurial ventures of the Korean Institutte of Science and Technology. Its representative director has applied for about 120 patents. Among them, 81 patents are actually registered while 31 patents are implemented. Now the company seeks USD 1.68 million for equity financing.
Asia - North Asia & China: Korea

Korean cancer treatment company seeks investment

The Korean cancer treatment company has a bioelectronic nose sensor which can detect cancer earlier than other sensors or instruments on the market. The examinee only needs to exhale on the inspection machine for about 1 minute to complete the inspection, and there is no discomfort during the inspection process. At present, the company has cooperated with Seoul National University Cancer Hospital, Renji Hospital, Korea Institute of science and Technology (KIST), etc. The company seeks investment now.
Asia - North Asia & China: Korea

Korean digital economy media company seeks USD 8.4 million investment.

The Korean company is a digital economy media enterprise established in 2018, providing real-time market information, news, and analysis of virtual assets, through various types of interviews. The company uses the information to help customers analyze and get solutions. Now, the company seeks USD 8.4 million for equity financing.
Asia - North Asia & China: Korea

Korean AI medical diagnosis firm seeks USD 2.5 million investment

The Korean AI medical company's products include a cervical cancer diagnosis AI system, an early AI diagnosis for stroke risk, a stroke risk prediction AI system based ob carotid ultrasound images, and a cerebral aneurysm rupture risk prediction AI system based on cerebral angiography images. The company has developed a international system with various languages to ensure that all medical personnel around the world can use its AI diagnosis solutions. Its partners include Swedish medical device manufacturer Gynius plus AB and Canadian health care company Variational AI. The company seeks USD 2.5 million for equity financing.
Asia - North Asia & China: Korea

Korea condiment company seeks USD 10 million investment

The Korean condiment company has successfully extracted salt from Salicornia, a halophyte flowering plant containing a large amount of salt, and developed the world's first plant based salt with 100% purity. A natural low-sodium salt, which can reduce sodium intake by 20% and have a significant effect on hypertension. The company also desalinated Salicornia and developed a new food that can effectively reduce body fat. In addition, the company developed healthy functional food materials and tea drinks that can effectively improve memory and cognitive ability by using Salicornia. It has 35 patents for Salicornia-based products. The company's round B equity financing seeks USD 10 million.
Middle East: Israel

Israeli medical equipment company seeks strategic partners and investment.

The Israeli medical equipment company has several innovative products. These products include drug delivery catheters (any drug, specific dose, platform technology), Vascular transplantation equipment, and special needles. The company seeks strategic partners and investment.
Middle East: Israel

Israeli company focuses on Ophthalmology seeks investment.

The Israeli company focuses on Ophthalmology and has a project which on a diagnostic solution that can provide multi-parameter, objective, rapid, simple, and semi quantitative tear film analysis to identify one or more potential causes. The project may not only become a clinically valuable real-time test, but also an auxiliary diagnostic test to meet the needs of rapid diagnosis and personalized medical treatment. The project is a cost-effective, easy-to-use, and objective solution that will enable eye care professionals to diagnose and treat patients, including patients who may not be diagnosed or whose condition remain uncertain. The company has completed three clinical trials in the United States and plans to carry out key trials with FDA. Now, the company seeks investment.
Middle East: Israel

Israeli medical company seeks investment for its Ophthalmic project.

The Israeli medical company is a joint venture, which authorizes the use of non-invasive local drug delivery technology, which is used to treat posterior ocular diseases by eye drops instead of current drug delivery methods (such as intravitreal injection). The platform technology can also be used for eye treatment. The project is currently in the preclinical stage of the development of a few candidate products. The company seeks investment for this project.
Middle East: Israel

Israeli cancer treatment center seeks investment.

The Israeli cancer treatment center has a project which specializes in the development and commercialization of innovative in vitro cancer diagnostic products and solutions. The product portfolio includes the latest technologies involving gene expression, biomarkers, and histochemical analysis for early cancer detection and personalized medicine. The project provides proprietary diagnostic solutions for a variety of cancer diagnostic applications and practical answers to unmet practical needs. The center seeks investment.
Middle East: Israel

Israeli medical company seeks investment.

The Israeli medical company has a product that is a microemulsion composed of phospholipids and triglycerides. It can form a tear film like elastic lipid shield to improve vision. It is a CE-certified III drug. Project is designated for post-operative ophthalmic surgery (e.g., refractive surgery, cataract surgery, and corneal transplantation), corneal erosion, and dry eye syndrome. This product is the only product on the eye drops market with clinical evidence that corneal epithelium thickens again after mechanical, traumatic, and surgical epithelial loss. As a microemulsion carrier, the technology can be used as a drug delivery platform in the pre-clinical stage. Its unique pharmaceutical advantages include a longer contact time between drug and eye surface which can increase compliance. The company seeks investment.

Filter

Enquire for more information about our services, and how we can help solve challenges for your organization

Contact Us
The code is case-sensitive